Changchun BCHT Biotechnology Co. (SHA:688276)

SHA:688276 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	277.89	442.18	866.54	1,156	309.63	272.98
Cash & Short-Term Investments	277.89	442.18	866.54	1,156	309.63	272.98
Cash Growth	-39.51%	-48.97%	-25.01%	273.22%	13.42%	29.73%
Accounts Receivable	1,671	1,567	968.41	763.94	733.18	330.73
Other Receivables	1.76	-	-	-	-	-
Receivables	1,673	1,567	968.41	763.94	733.18	330.73
Inventory	197.27	199.02	192.11	241.34	146.19	86.47
Prepaid Expenses	-	0.92	0.1	-	-	0.02
Other Current Assets	26.82	35.26	30.81	29.15	32.25	16.58
Total Current Assets	2,175	2,245	2,058	2,190	1,221	706.79
Property, Plant & Equipment	2,347	2,085	1,642	1,439	783.08	617.8
Long-Term Investments	184.55	207.57	61.28	69.12	10.23	7.3
Other Intangible Assets	332.58	347.45	204.02	223.72	248.57	74.74
Long-Term Deferred Tax Assets	124.86	90.97	54.2	31.93	20.96	9.05
Long-Term Deferred Charges	22.91	29.26	211.09	159.25	121.57	144.33
Other Long-Term Assets	127.54	41.06	53.06	61.95	61.85	23.34
Total Assets	5,314	5,046	4,284	4,175	2,468	1,583
Accounts Payable	13.75	17.49	24.8	63.91	34	16.55
Accrued Expenses	49.37	553.18	340.9	422.69	486.26	330.09
Short-Term Debt	25.81	20.47	-	-	-	165
Current Income Taxes Payable	56.94	48.89	5.07	-	18.24	1.66
Current Unearned Revenue	2.31	0.28	8.65	10.21	6.25	-
Other Current Liabilities	918.6	374.56	337.27	251.89	134.94	47.81
Total Current Liabilities	1,067	1,015	716.68	748.71	679.69	561.11
Long-Term Unearned Revenue	9.06	9.86	5.92	8.09	7.88	9.18
Long-Term Deferred Tax Liabilities	0.91	0.98	1.11	-	-	-
Other Long-Term Liabilities	0.36	0.17	0.31	0.25	-	-
Total Liabilities	1,114	1,026	724.02	757.05	687.57	570.29
Common Stock	413.66	412.84	412.84	412.84	371.56	130
Additional Paid-In Capital	1,838	1,820	1,778	1,771	416.29	77.75
Retained Earnings	2,001	1,819	1,380	1,240	1,023	834.87
Comprehensive Income & Other	-52.63	-31.86	-10.96	-5.75	-30.89	-29.56
Shareholders' Equity	4,200	4,020	3,560	3,418	1,780	1,013
Total Liabilities & Equity	5,314	5,046	4,284	4,175	2,468	1,583
Total Debt	62.58	20.47	-	-	-	165
Net Cash (Debt)	215.31	421.71	866.54	1,156	309.63	107.98
Net Cash Growth	-53.13%	-51.33%	-25.01%	273.22%	186.74%	-
Net Cash Per Share	0.52	1.02	2.10	2.94	0.84	0.30
Filing Date Shares Outstanding	413.66	412.84	412.84	412.84	371.56	362.33
Total Common Shares Outstanding	413.66	412.84	412.84	412.84	371.56	362.33
Working Capital	1,108	1,230	1,341	1,441	541.56	145.68
Book Value Per Share	10.15	9.74	8.62	8.28	4.79	2.80
Tangible Book Value	3,867	3,673	3,356	3,194	1,531	938.31
Tangible Book Value Per Share	9.35	8.90	8.13	7.74	4.12	2.59
Buildings	-	487.92	374.62	307.51	324.89	345.73
Machinery	-	826.34	509.79	451.85	426.37	398.87
Construction In Progress	-	1,101	1,038	919.84	235.49	38.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.